{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:45:56Z","timestamp":1772196356538,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.vaccine.2007.01.075","type":"journal-article","created":{"date-parts":[[2007,1,27]],"date-time":"2007-01-27T12:13:59Z","timestamp":1169900039000},"page":"3588-3594","source":"Crossref","is-referenced-by-count":16,"title":["Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine"],"prefix":"10.1016","volume":"25","author":[{"given":"Mingtao","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Pichichero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.01.075_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"Mock","year":"2001","journal-title":"Annu Rev Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.075_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0002-9440(10)63697-8","article-title":"Pathology and pathogenesis of bioterrorism-related inhalational anthrax","volume":"163","author":"Guarner","year":"2003","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.01.075_bib3","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0002-9440(10)63548-1","article-title":"The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax","volume":"163","author":"Shieh","year":"2003","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.01.075_bib4","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.addr.2005.01.028","article-title":"Molecular basis for improved anthrax vaccines","volume":"57","author":"Brey","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2007.01.075_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4049\/jimmunol.96.4.727","article-title":"Immunologic studies of anthrax.IV. Evaluation of the immunogenicity of three components of anthrax toxin","volume":"96","author":"Mahlandt","year":"1966","journal-title":"J Immunol"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2007.01.075_bib6","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2007.01.075_bib7","unstructured":"Anthrax Vaccine Adsorbed (BioThrax\u2122) Product Insert. BioPort Corporation, Lansing, Michigan; 2002."},{"issue":"22","key":"10.1016\/j.vaccine.2007.01.075_bib8","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","article-title":"Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax","volume":"282","author":"Friedlander","year":"1999","journal-title":"JAMA"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2007.01.075_bib9","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0264-410X(01)00387-5","article-title":"Anthrax vaccine: short-term safety experience in humans","volume":"20","author":"Pittman","year":"2001","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.01.075_bib10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/IAI.63.4.1369-1372.1995","article-title":"Protective immunity induced by Bacillus anthracis toxin-deficient strains","volume":"63","author":"Pezard","year":"1995","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2007.01.075_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00063030-200519040-00003","article-title":"Anthrax vaccines: a development update","volume":"19","author":"Little","year":"2005","journal-title":"BioDrugs"},{"issue":"7","key":"10.1016\/j.vaccine.2007.01.075_bib12","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect Immun"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2007.01.075_bib13","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2003.09.043","article-title":"Genetic immunization against anthrax","volume":"22","author":"Galloway","year":"2004","journal-title":"Vaccine"},{"issue":"January (5)","key":"10.1016\/j.vaccine.2007.01.075_bib14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.vaccine.2005.08.056","article-title":"N-fragment of edema factor as a candidate antigen for immunization against anthrax","volume":"24","author":"Zeng","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.075_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1128\/IAI.56.2.349-356.1988","article-title":"Immunological analysis of cell-associated antigens of Bacillus anthracis","volume":"56","author":"Ezzell","year":"1988","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2007.01.075_bib16","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/IAI.68.8.4549-4558.2000","article-title":"Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax","volume":"68","author":"Cohen","year":"2000","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2007.01.075_bib17","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0041-0101(01)00161-1","article-title":"Toxins of Bacillus anthracis","volume":"39","author":"Brossier","year":"2001","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.vaccine.2007.01.075_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-9433-4-4","article-title":"Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin","volume":"4","author":"Wang","year":"2005","journal-title":"Med Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.01.075_bib19","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1128\/IAI.73.9.5685-5696.2005","article-title":"Identification of a protein subset of the anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation","volume":"73","author":"Kudva","year":"2005","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2007.01.075_bib20","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.01.075_bib21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/IAI.51.3.795-800.1986","article-title":"Differences in susceptibility of inbred mice to Bacillus anthracis","volume":"51","author":"Welkos","year":"1986","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2007.01.075_bib22","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1128\/IAI.59.11.4061-4070.1991","article-title":"Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I\/II of Streptococcus mutans coupled to the cholera toxin B subunit","volume":"59","author":"Russell","year":"1991","journal-title":"Infect Immun"},{"issue":"32","key":"10.1016\/j.vaccine.2007.01.075_bib23","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2007.01.075_bib24","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0264-410X(98)00122-4","article-title":"Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin","volume":"16","author":"Hotomi","year":"1998","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2007.01.075_bib25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2007.01.075_bib26","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1073\/pnas.90.6.2291","article-title":"Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979","volume":"90","author":"Abramova","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2007.01.075_bib27","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.LAB.0000080599.43791.01","article-title":"Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis)","volume":"83","author":"Vasconcelos","year":"2003","journal-title":"Lab Invest"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2007.01.075_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.micpath.2005.02.001","article-title":"The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions","volume":"38","author":"Cote","year":"2005","journal-title":"Microb Pathog"},{"issue":"4","key":"10.1016\/j.vaccine.2007.01.075_bib29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/422694","article-title":"Induction of protective immunity against lethal anthrax challenge with a patch","volume":"190","author":"Kenney","year":"2004","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07001041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07001041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T14:47:19Z","timestamp":1683730039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07001041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":29,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0264410X07001041"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.01.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}